To determine mitral valve and extravalvular findings associated with mitral valve prolapse (MVP) in patients with the Marfan syndrome, we compared mitral leaflet and anular dimensions and motion by computerized two-dimensional echocardiography in 53 Marfan patients (28 with M-mode echocardiographic MVP) to those in 48 adults with primary MVP and in 35 normal subjects. Mitral leaflet billowing occurred in 28 of 28 Marfan patients with M-mode MVP versus 24 of 48 with primary MVP (p<0.00005), 0 of 25 Marfan patients without M-mode MVP, and 0 of 35 normal subjects (both, p <0.00001). Billowing occurred on the first systolic frame in 8 of 28 Marfan-MVP patients, in whom posterior leaflet chordae arose abnormally from the posterior ventricular wall, and in no other subjects. These patients had large mitral valves and normal anular dynamics, whereas the remaining 20 Marfan-MVP patients had increased systolic anular expansion. Marfan-MVP patients were younger than those without MVP (29± 12 vs. 38± 15 years,p<0.02) and had lower body mass index (19.8 ±2.7 vs. 23.9±2.9 kg/M2, p<0.00005) and systolic blood pressure (120+20 vs. 133±20 mm Hg, p<0.05), similar to diferences between primary MVP and normal subjects in body mass index (21.5±3.0 vs. 23.9±4.8 kg/m2, p<0.01) and systolic pressure (118±14 vs. 125±18 mm Hg, p<0.05). Marfan patients with and without MVP had similar arm span, arm span to height ratio, upper to lower segment ratio, and prevalence of ectopia lentis and thoracic bony abnormalities, but arachnodactyly was more frequent in those with MVP (82% and 48%, respectively; p<0.02). We conclude that 1) leaflet billowing occurs more uniformly in Marfan patients with MVP than in primary MVP, 2) MVP in Marfan patients may be due to either valve enlargement with distinctively abnormal chordal architecture or abnormal mitral anular distensibility, 3) Marfan patients with MVP have low body weight and systolic blood pressure, similar to primary MVP, and 4) Marfan patients with MVP more commonly have arachnodactyly but otherwise have similar skeletal and anthropometric characteristics to other Marfan patients. (Circulation 1989;80:915-924) 
Billowing occurred on the first systolic frame in 8 of 28 Marfan-MVP patients, in whom posterior leaflet chordae arose abnormally from the posterior ventricular wall, and in no other subjects. These patients had large mitral valves and normal anular dynamics, whereas the remaining 20 Marfan-MVP patients had increased systolic anular expansion. Marfan-MVP patients were younger than those without MVP (29± 12 vs. 38± 15 years,p<0.02) and had lower body mass index (19.8 ±2.7 vs. 23 .9±2.9 kg/M2, p<0.00005) and systolic blood pressure (120+20 vs. 133±20 mm Hg, p<0.05), similar to diferences between primary MVP and normal subjects in body mass index (21.5±3.0 vs. 23 .9±4.8 kg/m2, p<0.01) and systolic pressure (118±14 vs. 125±18 mm Hg, p<0.05). Marfan patients with and without MVP had similar arm span, arm span to height ratio, upper to lower segment ratio, and prevalence of ectopia lentis and thoracic bony abnormalities, but arachnodactyly was more frequent in those with MVP (82% and 48%, respectively; p<0.02). We conclude that 1) leaflet billowing occurs more uniformly in Marfan patients with MVP than in primary MVP, 2) MVP in Marfan patients may be due to either valve enlargement with distinctively abnormal chordal architecture or abnormal mitral anular distensibility, 3) Marfan patients with MVP have low body weight and systolic blood pressure, similar to primary MVP, and 4) Marfan patients with MVP more commonly have arachnodactyly but otherwise have similar skeletal and anthropometric characteristics to other Marfan patients. (Circulation 1989; 80:915-924) itral valve prolapse (MVP) occurs commonly as a primary, dominantly inher-V ited conditionl-3 and also as a secondary manifestation of a number of conditions, most notably the Marfan syndrome.4-6Although primary MVP and the Marfan syndrome are etiologically distinct, they resemble each other in being associated with extracardiac features including altered body habitus and certain thoracic bony abnormalities. 4 The eight Marfan patients excluded from further analyses were similar in age (mean=40 years), sex distribution (38% women), prevalence of MVP (50% by both M-mode and qualitative two-dimensional criteria with typical auscultatory features in all cases), and characteristics of body habitus to the 53 patients with technically excellent two-dimensional echocardiograms who comprised the study population. Marfan patients underwent a comprehensive skeletal, anthropometric, and ocular evaluation. According to criteria adapted from those of Pyeritz and McKusick,4 the diagnosis of the Marfan syndrome was made only when cardinal manifestations were present in at least two of the following four areas: a) the skeletal system (arachnodactyly, abnormal segment ratio, or marked kyphoscoliosis), b) the cardiovascular system (aortic root dilatation by two-dimensional echocardiography), c) the eyes (ectopia lentis), and d) the family history (positive diagnosis or death in a first-degree relative due to aortic dissection).
A group of normal adults and subjects with uncomplicated MVP who have been previously reported in part12"13 were used as comparison groups in the present study. These subjects were adults selected from the file of our large prospective study of MVP2,6,7 based on the availability of two-dimensional echocardiograms suitable for stopframe analysis of mitral valve dimensions on each frame throughout the cardiac cycle. Subjects with uncomplicated MVP met M-mode echocardiographic criteria for diagnosis of this condition, supported by typical auscultatory features on the present (88%) or previous (12%) auscultatory examinations, without clinical or echocardiographic evidence of hemodynamically significant mitral regurgitation by criteria previously reported from this laboratory,'4 whereas control subjects had normal mitral valves by M-mode echocardiogram and normal auscultatory examinations.
Echocardiographic Methods
Echocardiograms were performed by an experienced research technician with subjects in the partial left decubitus position, with the head of the bed elevated approximately 30°. Two-dimensional echocardiograms were recorded on 0.5-in. videotape using a Diasonics DRF 400 echocardiograph (Diasonics, Inc., Milpitas, California) or an HP 77020 echocardiograph (Hewlett-Packard, Andover, Massachusetts) with a 3.5 MHz transducer; Mmode tracings made using the same transducer were recorded on black and white strip-chart paper at 50 mm/sec. The accuracy of both horizontal and vertical calibrations of these machines was verified using an RMI phantom (Radiation Measurements, Inc., Middleton, Wisconsin). In patients with narrow intercostal spaces, additional M-mode recordings were made with a smaller independent transducer (Aerotech 2.25 MHz 13-mm diameter focused at 2-16 cm) using a Picker 80C echocardiograph (Picker, Inc, Northford, Connecticut).
Extensive recordings of the mitral valve were made from all available parasternal acoustic windows. M-mode tracings included multiple sweeps across the mitral valve from left ventricle to aorta along differently oriented paths as well as transverse scans of the valve, analogous to the T-scan introduced for left ventricular measurements by Henry et al. ' 1 Two-dimensional recordings of the mitral valve were made in multiple projections of parasternal long-and short-axis and apical four-chamber views in all subjects. Extensive Doppler recordings in both pulsed (3.5 mHz carrier frequency) and continuous wave (1.9 mHz carrier frequency) mode were performed from parasternal and apical windows to evaluate the presence and severity (by mapping the extent of regurgitant flow) of mitral and aortic regurgitation in 47 of 53 Marfan patients.
Computerized Analysis
Videotaped two-dimensional echocardiograms were reviewed using a Diasonics Cardio Review Center (option 4) that provided real-time and stopframe viewing formats. Analyses reported here used the parasternal long-axis view because of evidence that normal mitral valves may present an artifactual appearance of mitral prolapse in the apical fourchamber view due to the saddle shape of the mitral anulus.16,17 After repeated review of the study, a cardiac cycle was selected that allowed the best visualization of the anterior and posterior mitral leaflets from base to tip and the chord across the mitral anulus from the base of one leaflet to that of the other throughout the cardiac cycle. The entire systolic period (from the beginning of the R wave to the next opening of the mitral valve) of this cycle was examined frame by frame in stop-action format in long-axis view. In each framen the mitral anular The same proportion of probands was present in the Marfan and the primary MVP groups (34 of 53 or 64% and 30 of 48 or 63%, respectively). As shown in Table 1 , no difference was found in age or gender among subject groups. Midsystolic clicks, late systolic murmurs, or both were present in a higher percentage of subjects with uncomplicated mitral prolapse than in Marfan patients. Marfan patients had larger body surface areas than either controls or subjects with uncomplicated MVP. No difference was found in body mass index between Marfan patients and subjects with MVP, whereas both groups had lower body mass indexes than controls. Thoracic bony abnormalities (pectus excavatum or carinatum, scoliosis, or straight thoracic spine) were present in nearly all patients with Marfan syndrome, whereas 56% of subjects with primary MVP and only 11% of controls had one or more of these abnormal findings. Among subjects who underwent slit-lamp examination, ectopia lentis was present in 34 of 52, or 65%, of Marfan patients and was absent in four of four, or 100%, of MVP and one of one, or 100%, of normal subjects. Of the 53 Marfan patients, 35, or 66%, had positive family histories, three, or 6%, appeared to represent new mutations, and 15, or 28%, had incomplete family evaluations due to adoption or other circumstances. In the 26 families of subjects with MVP that were evaluated, one or more additional relatives was found to be affected in 24 (92%), among whom were six additional subjects in the present report.
Pattern of MVP
Billowing of one or both mitral leaflets into the left atrium during systole was demonstrated by analysis of two-dimensional recordings in 28 of 28, or 100%, of Marfan patients with M-mode echocardiographic MVP and 24 of 48, or 50%, of patients with primary MVP (p<0.00005). The remaining 24 patients with primary MVP (50%) demonstrated systolic anular expansion, as recently described.13 Two-dimensional echocardiograms in the latter group demonstrated posterior displacement of mitral leaflets both on qualitative review of the recordings and when points spaced equidistantly from base to free edge of the leaflets had their motion in the anterioposterior axis tracked by our computerized system. Leaflet billowing did not occur in any of the 25 Marfan patients or 35 normal subjects without Mmode echo or clinical evidence of MVP.
Computerized frame-by-frame two-dimensional echocardiographic examination of systolic mitral leaflet movements demonstrated that eight of 28 (29%) Marfan patients with MVP exhibited marked leaflet billowing on the first systolic frame, suggesting a lack of support by the subvalvular apparatus ( Figure IA) . Further, qualitative analysis of the two-dimensional recordings of these eight patients demonstrated the origin of all visualized posterior leaflet chordae to be from the left ventricular posterior wall rather than from a major papillary muscle ( Figure iB) Figure 2 ). However, the subgroup of Marfan patients with early systolic billowing had increased anterior leaflet length (2.33+0.28 vs. 1.97±0.24 cm in Marfan patients without early systolic billowing, p<0.01; p <0.02 vs. controls), with one value outside normal limits and the remaining seven patients toward the upper end of the normal distribution. Also, although anterior and posterior mitral leaflets in the entire group with uncomplicated MVP were similar to those in normal subjects, posterior leaflet length was greater in MVP subjects with systolic billowing than in those without (p<0.05).
Mitral Anular Diameter
Mitral anular diameter at end diastole was slightly increased in Marfan patients compared with normal subjects (2.88+0.50 vs. 2.68±0.39 cm,pn<0.05), but only four of 53, or 8%, of Marfan patients had end-diastolic anular diameter above the upper confidence limit derived from normal subjects ( Figure  3A) . However, the subgroup of Marfan patients with early systolic billowing had significantly Figure 3B , anular dimensions were outside normal limits in three of these eight patients cnd were toward the upper end of the normal distribution in the other five, whereas the remaining Marfan patients with and without MVP were within the normal range.
Although the entire group of Marfan patients had a normal percent increase in anular diameter from the minimum diameter attained in early systole to end systole (25+14% vs. 27+12%, NS), the patients without early systolic billowing exhibited increased anular expansion in midsystole to late systole compared with normal subjects, whereas the eight patients with early systolic billowing had normal anular dynamics (Figure 4 ). Among primary MVP subjects, only those without billowing had an increased anular expansion during systole (41 ± 14%, p<0.001, vs. controls).
Relation of Clinical Findings to Presence or Absence of Mitral Leaflet Billowing in Marfan Patients
Marfan patients with mitral leaflet billowing were younger than those without leaflet billowing (29+12 vs. 38±15 years,p<0.02), whereas the female predominance among Marfan patients with MVP (61% vs. 36% among patients without MVP, p=0.13) did not attain statistical significance (Table 3) .
Midsystolic clicks, late systolic murmurs, or both were present in 22 of 28, or 79%, of Marfan patients with leaflet billowing, but also in five of 25, or 20%, of Marfan patients without MVP. Patients with leaflet billowing had strikingly lower body mass indexes than those without billowing (19.8±2.7 vs. 23.9+2.9 kg/ m2,p<0.000005) and a lower systolic blood pressure (120±20 vs. 133±20 mm Hg, p<0.05). No difference was found in arm span, arm span to height ratio, upper to lower segment ratio, and ectopia lentis between patients with and without leaflet billowing, whereas arachnodactyly was more frequent in patients with billowing than in those without (82% vs. 48%, p<0.02). The two subgroups of Marfan patients exhibited the same frequency of thoracic bony abnormalities, scoliosis, and straight back.
Discussion
The present study confirms the occurrence of MVP in a majority of patients with Marfan syndrome that has been reported by previous investigators4 '30-35 the basis of systolic leaflet billowing, those with leaflet billowing exhibited subtle leaflet expansion and normal anular dynamics (partially analogous to the Marfan patients with early systolic prolapse), whereas those without leaflet billowing exhibited exaggerated anular distensibility (similar to the exaggerated mitral anular expansion seen in Marfan patients with midsystolic leaflet billowing). However, fundamental differences between MVP due to the Marfan syndrome and primary MVP were also evident, as early systolic prolapse in one Marfan subgroup was associated with an abnormal origin of posterior mitral leaflet chordae not seen in any patient with primary MVP, and increased mitral anular distension was associated with the presence of leaflet billowing in Marfan patients and with its absence in those with primary MVP. Although these differences in the mitral valve phenotype of primary MVP and MVP secondary to the Marfan syndrome are likely to reflect differences in the molecular bases of these conditions, attempts to identify the responsible genes have so far been futile. 36, 37 Marfan patients with MVP were younger and tended disproportionately to be women (61% vs. 36%, NS) than patients without MVP, a difference that partially explains the observation that Marfan patients with MVP had lower weight and body surface area than patients without MVP. However, Marfan patients with MVP were significantly leaner and had lower systolic blood pressure than Marfan patients without MVP, similar to differences in body mass index and systolic blood pressure between subjects with primary MVP and normal subjects. These differences were not attributable to a gender imbalance between Marfan patients with and without MVP, as body mass index was equally reduced among men and women with MVP (19.2+3.0 vs. 20.1+2.6 kg/M2, NS), parallel to the similarity in body mass indexes of normal men and women.38 Further, Marfan patients with MVP presented a similar prevalence of typical auscultatory findings (midsystolic clicks, late systolic murmurs, or both) as subjects with primary MVP. However, the typical auscultatory features that were detected in a surprising percentage (five of 25, or 20%) of Marfan patients without echocardiographic MVP appeared to have a variety of causes. One woman, age 58 years, had mitral anular calcification, associated with mild mitral regurgitation on one of two Doppler studies; one man, age 25 years, had imaging echocardiograms that were suggestive but never diagnostic of MVP, with minimal mitral regurgitation on three of six Doppler studies; one man, age 24 years, may have had a false-negative echocardiogram for MVP in this study as one of three subsequent studies barely met diagnostic criteria. Another man, age 28 years, had four normal imaging studies of the mitral valve at New York Hospital but developed mild mitral regurgitation on serial Doppler examinations, as left ventricular dilatation developed parallel with the onset of aortic regurgitation due to aortic root dilatation; and the final man, age 41 years, with a late systolic murmur but normal imaging study of the mitral valve, had separated from his family and declined follow-up in our institution or elsewhere.
Despite the difference in body build between Marfan patients with and without MVP, anthropometric, skeletal, and ocular examinations did not differ between the subgroups defined by the presence or absence of MVP; only arachnodactyly was more frequent in Marfan patients with MVP than in those without. The primary MVP patients exhibited a significantly higher prevalence of thoracic bony abnormalities than normal subjects but a lower one than among Marfan patients.
Computerized analyses of two-dimensional echocardiograms demonstrates that the MVP occurring as a secondary feature in a majority of Marfan patients differs from primary MVP, both with regard to the pattern of mitral leaflet motion (billowing in 100% versus 50% of subjects with primary MVP) and with regard to a distinctive disturbance of valvular architecture, with the origin of all visualized posterior leaflet chordae directly from the posterior left ventricular wall, in a subset of Marfan patients with MVP. This observation adds abnormal chordal support as a fourth in vivo mechanism of MVP to the three mechanisms that have been documented by previous echocardiographic studies: mitral leaflet and anular enlargement,12'39 abnormal mitral anular distensibility,13 and reduction in left ventricular size due to conditions such as atrial septal defect40 and anorexia nervosa.41 Similar to observations in non-Marfan subjects, Marfan patients with MVP were strikingly thinner and had lower systolic arterial pressure than those without MVP. At present the biologic basis of these differences is unknown both in the Marfan syndrome and in primary MVP. Further, our data demonstrated that although arachnodactyly was statistically more common in Marfan patients with MVP, the anthro-pometric and skeletal examination does not clearly differentiate Marfan patients with and without MVP.
